Annual Total Long Term Liabilities
$936.00 K
-$324.00 K-25.71%
31 December 2023
Summary:
Viking Therapeutics annual total long term liabilities is currently $936.00 thousand, with the most recent change of -$324.00 thousand (-25.71%) on 31 December 2023. During the last 3 years, it has risen by +$907.00 thousand (+3127.59%). VKTX annual total long term liabilities is now -80.24% below its all-time high of $4.74 million, reached on 31 December 2015.VKTX Long Term Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Long Term Liabilities
$755.00 K
-$11.00 K-1.44%
30 September 2024
Summary:
Viking Therapeutics quarterly total long term liabilities is currently $755.00 thousand, with the most recent change of -$11.00 thousand (-1.44%) on 30 September 2024. Over the past year, it has dropped by -$263.00 thousand (-25.83%). VKTX quarterly long term liabilities is now -85.11% below its all-time high of $5.07 million, reached on 31 March 2016.VKTX Quarterly Long Term Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
VKTX Long Term Liabilities Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -25.7% | -25.8% |
| 3 y3 years | +3127.6% | +100.0% |
| 5 y5 years | +7700.0% | +72.4% |
VKTX Long Term Liabilities High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -25.7% | -49.3% | ||
| 5 y | 5 years | -25.7% | -49.3% | ||
| alltime | all time | -80.2% | -85.1% |
Viking Therapeutics Long Term Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $755.00 K(-1.4%) |
| June 2024 | - | $766.00 K(-10.1%) |
| Mar 2024 | - | $852.00 K(-9.0%) |
| Dec 2023 | $936.00 K(-25.7%) | $936.00 K(-8.1%) |
| Sept 2023 | - | $1.02 M(-7.5%) |
| June 2023 | - | $1.10 M(-6.9%) |
| Mar 2023 | - | $1.18 M(-6.3%) |
| Dec 2022 | $1.26 M(>+9900.0%) | $1.26 M(-5.8%) |
| Sept 2022 | - | $1.34 M(-5.4%) |
| June 2022 | - | $1.41 M(-5.1%) |
| Mar 2022 | - | $1.49 M(>+9900.0%) |
| Dec 2021 | $0.00(-100.0%) | $0.00(0.0%) |
| Sept 2021 | - | $0.00(0.0%) |
| June 2021 | - | $0.00(0.0%) |
| Mar 2021 | - | $0.00(-100.0%) |
| Dec 2020 | $29.00 K(-91.9%) | $29.00 K(-74.8%) |
| Sept 2020 | - | $115.00 K(-41.9%) |
| June 2020 | - | $198.00 K(-29.0%) |
| Mar 2020 | - | $279.00 K(-22.5%) |
| Dec 2019 | $360.00 K | $360.00 K(-17.8%) |
| Sept 2019 | - | $438.00 K(-14.6%) |
| June 2019 | - | $513.00 K(-12.8%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2019 | - | $588.00 K(+4800.0%) |
| Dec 2018 | $12.00 K(>+9900.0%) | $12.00 K(>+9900.0%) |
| Sept 2018 | - | $0.00(0.0%) |
| June 2018 | - | $0.00(0.0%) |
| Mar 2018 | - | $0.00(0.0%) |
| Dec 2017 | $0.00(-100.0%) | $0.00(0.0%) |
| Sept 2017 | - | $0.00(-100.0%) |
| June 2017 | - | $6100.00(-99.9%) |
| Mar 2017 | - | $4.22 M(>+9900.0%) |
| Dec 2016 | $16.30 K(-99.7%) | $16.30 K(-20.5%) |
| Sept 2016 | - | $20.50 K(-16.7%) |
| June 2016 | - | $24.60 K(-99.5%) |
| Mar 2016 | - | $5.07 M(+7.0%) |
| Dec 2015 | $4.74 M(+78.5%) | $4.74 M(>+9900.0%) |
| Sept 2015 | - | $19.10 K(>+9900.0%) |
| June 2015 | - | $0.00(-100.0%) |
| Mar 2015 | - | $2.90 M(+9.2%) |
| Dec 2014 | $2.65 M(+774.7%) | $2.65 M(+103.6%) |
| June 2014 | - | $1.30 M(+308.5%) |
| Mar 2014 | - | $319.10 K |
| Dec 2013 | $303.50 K(+495.1%) | - |
| Dec 2012 | $51.00 K | - |
FAQ
- What is Viking Therapeutics annual total long term liabilities?
- What is the all time high annual total long term liabilities for Viking Therapeutics?
- What is Viking Therapeutics annual total long term liabilities year-on-year change?
- What is Viking Therapeutics quarterly total long term liabilities?
- What is the all time high quarterly long term liabilities for Viking Therapeutics?
- What is Viking Therapeutics quarterly long term liabilities year-on-year change?
What is Viking Therapeutics annual total long term liabilities?
The current annual total long term liabilities of VKTX is $936.00 K
What is the all time high annual total long term liabilities for Viking Therapeutics?
Viking Therapeutics all-time high annual total long term liabilities is $4.74 M
What is Viking Therapeutics annual total long term liabilities year-on-year change?
Over the past year, VKTX annual total long term liabilities has changed by -$324.00 K (-25.71%)
What is Viking Therapeutics quarterly total long term liabilities?
The current quarterly long term liabilities of VKTX is $755.00 K
What is the all time high quarterly long term liabilities for Viking Therapeutics?
Viking Therapeutics all-time high quarterly total long term liabilities is $5.07 M
What is Viking Therapeutics quarterly long term liabilities year-on-year change?
Over the past year, VKTX quarterly total long term liabilities has changed by -$263.00 K (-25.83%)